The Joint Corp. JYNT R2K
Healthcare · Medical Care Facilities · United States
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
READ MORE ›$8.90
-16.82% 1Y
Market & Price
Market Cap
$126.87M
Current Price
$8.90
High / Low (52W)
$12.51 / $7.67
Beta
1.11
Valuation
Stock P/E
98.89
Industry PE
23.65
Forward P/E
20.54
PEG Ratio
8.83
Book Value
$1.13
Price to Book
7.88
P/S
2.24
EV/EBITDA
43.96
Dividend Yield
-
Profitability & Returns
ROCE
-3.22%
ROE
7.00%
ROA
0.61%
Profit Margin
5.72%
Op Margin
6.07%
EPS (Latest Qtr)
$0.09
EPS (TTM)
$0.09
Balance Sheet & Liquidity
Debt/Equity
0.13
Quick Ratio
0.76
Current Ratio
1.64
Debt
$2.04M
Total Assets
$60.97M
Current Assets
$52.09M
Working Capital
$19.27M
Ownership
Promoter Holding
16.07%
Chg in Prom Hold
-
FII / Inst Holding
74.21%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
$103.25M
Total Revenue (TTM)
$56.64M
EBITDA
$2.35M
Free Cash Flow
$9.30M
Operating Cash Flow
$4.06M
Shares Outstanding
14.26M
Gross Margin
80.62%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
-18.46%
Profit 5Y
66.78%
Revenue (YoY)
13.30%
Earnings (YoY)
43.80%
PROS
- Profit CAGR of 66.8% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 98.9.
- Revenue declined at -18.5% CAGR over 5 years.
- Trading 28.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JYNT The Joint Corp. R2K | 8.90 | 98.89 | $126.87M | - | -3.22% | 7.00% | -18.46% | 66.78% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.51M | 1.73M | 1.82M | 2.51M | 3.43M | 4.14M | 4.27M | 4.97M | 5.50M | 5.51M | 6.00M | 6.54M | 8.65M | 8.80M | 9.24M | 10.68M | 11.17M | 12.73M | 13.64M | 12.59M | 15.41M | 17.55M | 20.22M | 20.99M | 22.44M | 24.89M | 26.45M | 28.30M | 29.31M | 29.47M | - | 29.72M | 30.26M | 30.20M | - | 13.08M | 13.27M | 13.38M | 15.17M | 14.82M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.97M | 2.77M | 2.66M | 2.82M | 2.72M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.11M | 10.50M | 10.72M | 12.35M | 12.10M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.78M | 11.63M | 10.56M | 11.60M | 11.20M |
| Operating Income | -157.39K | -209.16K | -310.82K | -1.92M | -1.85M | -2.05M | -3.48M | -3.19M | -2.62M | -1.71M | -995.53K | -405.53K | -83.78K | -64.24K | -247.04K | 943.67K | 487.60K | 640.38K | 753.35K | 258.58K | 1.71M | 1.97M | 2.03M | 1.34M | -176.43K | -1.33M | 732.32K | -257.89K | -414.64K | -3.82K | 994.64K | -426.60K | -1.78M | -492.82K | 809.72K | -676.56K | -1.13M | 160.91K | 743.89K | 899.00K |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -288.25K | -714.31K | 623.96K | 1.19M | 1.30M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -492.62K | -978.25K | 300.72K | 940.64K | 1.11M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.40K | 11.39K | 10.35K | 3.51K | 11.11K |
| Net Income | -127.89K | -133.75K | -202.37K | -1.90M | -1.86M | -1.66M | -3.53M | -3.26M | -2.63M | -1.77M | -1.02M | -431.70K | -31.61K | -50.84K | -207.54K | 952.64K | 462.26K | 616.98K | 814.95K | 115.58K | 1.60M | 2.31M | 2.68M | 1.94M | -205.80K | -871.87K | 731.10K | 2.33M | -320.49K | -716.27K | - | 946.98K | -3.60M | -3.17M | - | 967.80K | 93.36K | 855.01K | 991.10K | 1.30M |
| Diluted EPS | - | - | -0.04 | - | - | - | - | - | - | - | - | - | 0.00 | - | -0.02 | 0.07 | 0.03 | 0.04 | 0.06 | 0.01 | 0.11 | 0.16 | 0.18 | 0.13 | -0.01 | -0.06 | 0.05 | 0.16 | -0.02 | -0.05 | -0.74 | 0.06 | -0.24 | -0.21 | 0.00 | 0.05 | 0.01 | 0.06 | 0.07 | 0.09 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 36.66M | - | - | - | 101.25M | 46.98M | 52.16M | 54.90M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | - | - | - | - | - | - | - | - | - | 92.08M | 36.50M | 40.65M | 43.67M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 90.84M | 36.20M | 42.47M | 44.58M |
| Operating Income | 439.79K | -1.63M | -9.32M | -15.01M | -3.33M | 142.56K | 3.41M | 5.49M | 5.35M | 1.24M | 297.40K | -1.82M | -905.48K |
| EBITDA | - | - | - | - | - | - | - | - | - | 7.89M | 8.88M | 2.90M | 808.24K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | 695.15K | 254.01K | -1.61M | -229.50K |
| Tax Provision | - | - | - | - | - | - | - | - | - | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 155.63K | -3.03M | -8.80M | -15.17M | -3.43M | 146.70K | 3.32M | 13.17M | 6.58M | 626.71K | -9.75M | -5.80M | 2.91M |
| Diluted EPS | 0.02 | -0.56 | - | - | -0.26 | 0.01 | 0.23 | 0.90 | 0.44 | 0.08 | -0.66 | -0.57 | 0.19 |
Compounded Sales Growth
| 5 Years: | -18.46% |
| 1 Year: | 13.30% |
Compounded Profit Growth
| 5 Years: | 66.78% |
| 1 Year: | 43.80% |
Stock Price Performance
| 1 Year: | -16.82% |
| 6 Months: | +4.83% |
| 3 Months: | +1.14% |
| 1 Month: | +0.45% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 9.77M | 28.47M | 33.36M | 17.05M | 18.44M | 23.43M | 43.71M | 65.88M | - | 93.49M | 87.21M | 83.15M | 60.97M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 17.61M | 44.34M | 74.58M | 52.09M |
| Cash & Equivalents | 3.57M | 3.52M | 20.80M | 16.79M | 3.01M | 4.22M | 8.72M | 8.46M | 20.55M | - | 9.75M | 18.15M | 25.05M | 23.60M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | 3.91M | 2.58M | 2.59M | 2.85M |
| Total Liabilities | - | 10.99M | 12.84M | 12.68M | 10.13M | 17.28M | 22.70M | 37.99M | 44.75M | - | 60.90M | 62.44M | 62.48M | 45.89M |
| Current Liabilities | - | 3.59M | 4.18M | 7.49M | 5.86M | 5.38M | 10.27M | 13.57M | 18.46M | - | 23.22M | 33.57M | 49.04M | 32.82M |
| Long Term Debt | - | - | - | 581.85K | 331.50K | 100.00K | - | - | - | 2.00M | 2.00M | 2.00M | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | 26.06M | 2.86M | 795.03K | 2.01M |
| Total Equity | -1.14M | -1.22M | 15.63M | 20.68M | 6.93M | 1.15M | 727.50K | 5.72M | 21.13M | - | 32.56M | 24.75M | 20.65M | 15.05M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 14.56M | 14.78M | 15.19M | 15.47M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | -10.85M | -74.13K | 5.45M | 7.52M | 11.18M | - | 8.21M | 14.68M | 9.42M | 1.84M |
| Investing Cash Flow | - | - | - | -2.70M | -372.85K | -1.24M | -7.14M | -4.60M | - | -17.90M | -6.19M | -631.55K | 6.27M |
| Financing Cash Flow | - | - | - | -239.85K | 1.42M | 326.30K | -596.96K | 5.60M | - | 328.61K | 174.12K | -2.00M | -9.81M |
| Capital Expenditure | -241.41K | -659.30K | -4.07M | -1.57M | -449.20K | -1.11M | -3.48M | -3.16M | - | -5.90M | -5.00M | -1.19M | -1.50M |
| Free Cash Flow | - | - | - | -12.42M | -523.34K | 4.34M | 4.04M | 8.03M | - | 2.31M | 9.68M | 8.23M | 334.72K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | -9.36M | 8.66M | 6.78M | -1.69M |
| Share Buybacks | 240.00K | - | - | 83.39K | 2.65K | 4.81K | 20.18K | 32.07K | 707.73K | 5.80K | 3.83K | 0 | 11.31M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | 90.9% | 77.7% | 77.9% | 79.6% |
| Operating Margin % | - | - | - | - | - | 0.4% | - | - | - | 1.2% | 0.6% | -3.5% | -1.6% |
| Net Margin % | - | - | - | - | - | 0.4% | - | - | - | 0.6% | -20.8% | -11.1% | 5.3% |
| ROE % | -12.7% | -19.4% | -42.5% | -219.1% | -297.6% | 20.2% | 58.1% | 62.3% | - | 1.9% | -39.4% | -28.1% | 19.3% |
| ROCE % | 7.1% | -6.7% | -36.0% | -134.1% | -25.5% | 1.1% | 11.3% | 11.6% | - | 1.8% | 0.6% | -5.3% | -3.2% |
Shareholding Pattern
Insiders
16.07%
Institutions
74.21%
Public Float
88.42%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Bandera Partners LLC | 27.62% | 3.94M | $35.04M |
| 2 | Skylands Capital, LLC | 6.27% | 893.20K | $7.95M |
| 3 | Blackrock Inc. | 5.29% | 754.52K | $6.72M |
| 4 | Vanguard Capital Management LLC | 4.18% | 595.61K | $5.30M |
| 5 | JCP Investment Management, LLC | 4.17% | 593.91K | $5.29M |
| 6 | First Foundation Advisors | 2.37% | 337.85K | $3.01M |
| 7 | Russell Investments Group, Ltd. | 2.26% | 321.86K | $2.86M |
| 8 | Geode Capital Management, LLC | 2.02% | 287.41K | $2.56M |
| 9 | State Street Corporation | 2.00% | 285.61K | $2.54M |
| 10 | Vanguard Portfolio Management LLC | 1.95% | 277.64K | $2.47M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for JYNT
No recent headlines available.